What are the key findings of the GREek Atorvastatin and Coronary-heart-disease Evaluation (GREACE) study?
The GREek Atorvastatin and Coronary-heart-disease Evaluation (GREACE) study found that treatment with atorvastatin to the National Cholesterol Educational Program goal was more effective than usual care in secondary coronary heart disease prevention. Patients who received atorvastatin experienced a significantly greater reduction in total cardiovascular events than patients receiving usual care. Additionally, the study showed that treatment with atorvastatin was associated with a significant reduction in all-cause mortality, with an absolute risk reduction of 3.2%. The findings of the GREACE study suggest that atorvastatin is beneficial in secondary coronary heart disease prevention.